Compare, Analyse IPCA Labs with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ACTAVIS (US) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ACTAVIS
EQUITY SHARE DATA
    IPCA LABS
Mar-18
ACTAVIS
Dec-18
IPCA LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs69513,754-   
Low Rs4009,226-   
Sales per share (Unadj.) Rs260.23,373.8-  
Earnings per share (Unadj.) Rs19.0-1,086.7-  
Cash flow per share (Unadj.) Rs33.1355.5-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs213.013,915.5-  
Shares outstanding (eoy) m126.20332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.13.4 61.8%   
Avg P/E ratio x28.9-10.6 -273.0%  
P/CF ratio (eoy) x16.632.3 51.3%  
Price / Book Value ratio x2.60.8 311.4%  
Dividend payout %5.30-   
Avg Mkt Cap Rs m69,1203,821,601 1.8%   
No. of employees `00013.316.9 78.4%   
Total wages/salary Rs m7,3590-   
Avg. sales/employee Rs Th2,477.466,398.8 3.7%   
Avg. wages/employee Rs Th555.20-   
Avg. net profit/employee Rs Th180.6-21,387.1 -0.8%   
INCOME DATA
Net Sales Rs m32,8361,122,140 2.9%  
Other income Rs m41821,459 1.9%   
Total revenues Rs m33,2541,143,599 2.9%   
Gross profit Rs m4,50529,406 15.3%  
Depreciation Rs m1,777479,690 0.4%   
Interest Rs m24064,754 0.4%   
Profit before tax Rs m2,905-493,580 -0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0125,883 0.0%   
Tax Rs m511-6,255 -8.2%   
Profit after tax Rs m2,394-361,442 -0.7%  
Gross profit margin %13.72.6 523.5%  
Effective tax rate %17.61.3 1,388.2%   
Net profit margin %7.3-32.2 -22.6%  
BALANCE SHEET DATA
Current assets Rs m19,455460,243 4.2%   
Current liabilities Rs m10,076407,146 2.5%   
Net working cap to sales %28.64.7 603.7%  
Current ratio x1.91.1 170.8%  
Inventory Days Days9820 499.9%  
Debtors Days Days6766 101.0%  
Net fixed assets Rs m20,260127,020 15.9%   
Share capital Rs m2520-   
"Free" reserves Rs m26,6330-   
Net worth Rs m26,8864,628,303 0.6%   
Long term debt Rs m2,3401,629,793 0.1%   
Total assets Rs m41,1737,235,091 0.6%  
Interest coverage x13.1-6.6 -197.7%   
Debt to equity ratio x0.10.4 24.7%  
Sales to assets ratio x0.80.2 514.2%   
Return on assets %6.4-4.1 -156.0%  
Return on equity %8.9-7.8 -114.0%  
Return on capital %10.8-4.8 -222.3%  
Exports to sales %47.60-   
Imports to sales %14.90-   
Net fx Rs m10,7590-   
CASH FLOW
From Operations Rs m3,411400,898 0.9%  
From Investments Rs m-1,354220,241 -0.6%  
From Financial Activity Rs m-1,304-688,062 0.2%  
Net Cashflow Rs m753-66,588 -1.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare IPCA LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: FDC LTD.  WOCKHARDT  DR. REDDYS LAB  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Key Q2FY20 Results, BHEL Stake Sale, and Top Cues in Focus Today(Pre-Open)

On Friday, Indian share markets traded on a positive note most of the day and ended higher. The BSE Sensex logged total gains of 1,417 points in the past six sessions.

Related Views On News

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Oct 18, 2019 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS